Semaglutide is a GLP-1 receptor agonist used in certain prescription medications. Wegovy is an FDA-approved, once-weekly injection for chronic weight management in eligible patients when used with reduced-calorie nutrition and increased physical activity. Ozempic contains the same active ingredient but has different FDA-approved uses.

Semaglutide acts on pathways involved in appetite, digestion, and glucose regulation. It may help some patients feel satisfied sooner and remain satisfied longer by affecting appetite signals and slowing gastric emptying. Individual responses vary, and the medication is not appropriate for everyone.

Depending on a patient’s individual needs, a provider may discuss compounded Semaglutide as a treatment option. Keystone obtains its compounded medication from an FDA-registered 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality in the same manner as FDA-approved products.

As part of an individualized medical weight-management plan, Semaglutide may support:

• Appetite regulation: Some patients may experience reduced hunger or earlier feelings of fullness.
• Reduced calorie intake: Changes in appetite may make it easier for some patients to follow an appropriate nutrition plan.
• Glucose regulation: Semaglutide affects pathways involved in blood-sugar management.

Treatment may also cause side effects and carries potential risks, contraindications, and medication interactions. Your provider will review your medical history, current medications, treatment goals, and available alternatives before determining whether Semaglutide may be appropriate. Individual results vary, and no specific amount or duration of weight loss can be guaranteed.

Keystone Medical Wellness provides medical weight-management consultations for patients in Queen Creek, Chandler, Gilbert, Mesa, and surrounding Arizona communities. Call us or request an appointment online to learn whether medical weight management may be appropriate for you.

Tirzepatide is a prescription medication that acts on both GIP and GLP-1 receptors involved in appetite, digestion, and glucose regulation. FDA-approved medications containing Tirzepatide include Zepbound, which is approved for chronic weight management in certain eligible patients, and Mounjaro, which has different FDA-approved uses.

By acting on these two receptor pathways, Tirzepatide may help some patients experience reduced hunger, earlier feelings of fullness, and improved glucose regulation. Individual responses vary, and the medication is not appropriate for everyone.

Depending on a patient’s individual needs, a provider may discuss compounded Tirzepatide as a treatment option. Keystone obtains its compounded medication from an FDA-registered 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality in the same manner as FDA-approved products.

As part of an individualized medical weight-management plan, Tirzepatide may support:

• Appetite regulation: Some patients may experience reduced hunger or fewer food cravings.
• Satiety: Patients may feel satisfied sooner or remain satisfied longer after eating.
• Reduced calorie intake: Changes in appetite may help some patients follow an appropriate nutrition plan.
• Glucose regulation: Tirzepatide affects pathways involved in blood-sugar management.

Tirzepatide can cause side effects and carries potential risks, contraindications, and medication interactions. Your provider will review your medical history, current medications, treatment goals, and available alternatives before determining whether Tirzepatide may be appropriate. Individual results vary, and no specific amount or rate of weight loss can be guaranteed.

Keystone Medical Wellness provides medical weight-management consultations for patients in Mesa, Queen Creek, Chandler, Gilbert, and surrounding Arizona communities. Call us or request an appointment online to learn whether medical weight management may be appropriate for you.

Don’t see what you are looking for? Additional GLP-1–based treatment options may be available depending on your medical history, previous treatment response, clinical needs, and current medication availability. Schedule a consultation to discuss which options, if any, may be appropriate for you.

During your consultation, a licensed provider will review the options that may be clinically appropriate for you, including potential benefits, risks, alternatives, monitoring requirements, availability, and costs.

Treatment options may change as medications, clinical guidance, and availability evolve. Not every treatment is appropriate for every patient, and a consultation does not guarantee that medication will be prescribed.

Call us or request an appointment online to discuss your available options.

Phentermine is an oral prescription medication FDA-approved for short-term use as part of a broader weight-management plan. Treatment may also include reduced-calorie nutrition, physical activity, behavioral changes, and provider follow-up.

Phentermine works by helping reduce appetite and may be considered for certain adults who meet clinical eligibility criteria. It is not appropriate for everyone, including patients with a history of certain cardiovascular conditions or uncontrolled high blood pressure. Other medical conditions, contraindications, side effects, and medication interactions may also affect eligibility.

If Phentermine is prescribed, your provider will give you individualized instructions regarding dosage, timing, treatment duration, and monitoring. These decisions are based on your medical history, current medications, blood pressure, treatment response, and clinical needs rather than a desired amount of weight loss alone.

Individual experiences and results vary. Phentermine should only be used as prescribed and with appropriate medical supervision.

Human Chorionic Gonadotropin, or HCG, is a prescription hormone with FDA-approved uses for certain fertility and hormone-related conditions. HCG is not FDA-approved for weight loss.

Over the years, some weight-management programs have combined HCG injections with a medically supervised reduced-calorie nutrition plan. However, current evidence has not established that HCG increases weight loss beyond the effects of calorie restriction alone, promotes targeted fat loss, preserves muscle mass, or reduces the discomfort associated with calorie restriction.

Highly restrictive diets, including plans providing approximately 500 calories per day, may carry serious health risks. Potential concerns include nutrient deficiencies, electrolyte imbalances, gallstones, and irregular heart rhythms. Such diets should not be undertaken without an individualized clinical evaluation and close medical supervision.

Your provider will review your medical history, current medications, treatment goals, potential risks, and evidence-based alternatives before determining which weight-management approach may be appropriate. Individual results vary, and no specific amount or rate of weight loss can be guaranteed.